Anna Filonenko

ORCID: 0000-0003-4553-0534 · 6 papers in corpus
2019
·doi:10.1016/j.jval.2019.04.870
2015
·doi:10.1016/j.jval.2015.03.158
2014
·doi:10.1016/j.jval.2014.03.1159
rct 2013
Journal of women's health (2002) ·doi:10.1089/jwh.2012.3633

OBJECTIVES: To quantify the change in work productivity and activities of daily living in North American women with heavy menstrual bleeding (HMB) treated with estradiol valerate/dienogest (E2V/DNG; Qlaira(®)/Natazia(®)) compared to placebo…

2011
·doi:10.1016/j.jval.2011.08.970
2009
·doi:10.1016/s1098-3015(10)74450-8